Premium
A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma
Author(s) -
Mudigonda Tejaswi V.,
Wyman Kenneth,
Spigel David R.,
Dahlman Kimberly B.,
Greco F. Anthony,
Puzanov Igor,
Kelley Mark C.,
Hainsworth John D.,
Sosman Jeffrey A.,
Johnson Douglas B.
Publication year - 2016
Publication title -
pigment cell and melanoma research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.618
H-Index - 105
eISSN - 1755-148X
pISSN - 1755-1471
DOI - 10.1111/pcmr.12394
Subject(s) - bevacizumab , erlotinib , medicine , metastatic melanoma , table (database) , oncology , cancer , computer science , database , chemotherapy , epidermal growth factor receptor